annual total liabilities:
$3.24B-$1.33B(-29.11%)Summary
- As of today (May 19, 2025), MRNA annual total liabilities is $3.24 billion, with the most recent change of -$1.33 billion (-29.11%) on December 31, 2024.
- During the last 3 years, MRNA annual total liabilities has fallen by -$7.28 billion (-69.20%).
- MRNA annual total liabilities is now -69.20% below its all-time high of $10.52 billion, reached on December 31, 2021.
Performance
MRNA Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$2.64B-$603.00M(-18.61%)Summary
- As of today (May 19, 2025), MRNA quarterly total liabilities is $2.64 billion, with the most recent change of -$603.00 million (-18.61%) on March 31, 2025.
- Over the past year, MRNA quarterly total liabilities has dropped by -$1.27 billion (-32.57%).
- MRNA quarterly total liabilities is now -75.57% below its all-time high of $10.80 billion, reached on September 30, 2021.
Performance
MRNA quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MRNA Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.1% | -32.6% |
| 3 y3 years | -69.2% | -75.0% |
| 5 y5 years | +681.7% | +518.3% |
MRNA Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -69.2% | at low | -75.0% | at low |
| 5 y | 5-year | -69.2% | +681.7% | -75.6% | +518.3% |
| alltime | all time | -69.2% | >+9999.0% | -75.6% | >+9999.0% |
MRNA Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.64B(-18.6%) |
| Dec 2024 | $3.24B(-29.1%) | $3.24B(-16.4%) |
| Sep 2024 | - | $3.88B(-2.3%) |
| Jun 2024 | - | $3.97B(+1.4%) |
| Mar 2024 | - | $3.91B(-14.4%) |
| Dec 2023 | $4.57B(-32.1%) | $4.57B(-23.7%) |
| Sep 2023 | - | $6.00B(+21.5%) |
| Jun 2023 | - | $4.93B(-6.2%) |
| Mar 2023 | - | $5.26B(-21.9%) |
| Dec 2022 | $6.74B(-36.0%) | $6.74B(-16.5%) |
| Sep 2022 | - | $8.06B(+0.1%) |
| Jun 2022 | - | $8.06B(-23.5%) |
| Mar 2022 | - | $10.53B(+0.1%) |
| Dec 2021 | $10.52B(+120.4%) | $10.52B(-2.5%) |
| Sep 2021 | - | $10.80B(+14.3%) |
| Jun 2021 | - | $9.45B(+6.7%) |
| Mar 2021 | - | $8.86B(+85.4%) |
| Dec 2020 | $4.78B(+1051.9%) | $4.78B(+152.6%) |
| Sep 2020 | - | $1.89B(+250.8%) |
| Jun 2020 | - | $539.12M(+26.4%) |
| Mar 2020 | - | $426.67M(+2.9%) |
| Dec 2019 | $414.61M(-4.0%) | $414.61M(+22.3%) |
| Sep 2019 | - | $339.09M(-2.2%) |
| Jun 2019 | - | $346.73M(-3.7%) |
| Mar 2019 | - | $360.17M(-16.6%) |
| Dec 2018 | $431.91M(-5.9%) | $431.91M(+4.6%) |
| Sep 2018 | - | $412.73M(-10.1%) |
| Dec 2017 | $459.19M(-20.2%) | $459.19M(+9851.1%) |
| Sep 2017 | - | $4.61M(+11.0%) |
| Jun 2017 | - | $4.16M(+54.1%) |
| Mar 2017 | - | $2.70M(-9.1%) |
| Dec 2016 | $575.31M(+7746.6%) | - |
| Dec 2016 | - | $2.97M(-45.8%) |
| Sep 2016 | - | $5.48M(-9.8%) |
| Jun 2016 | - | $6.07M(+6.7%) |
| Mar 2016 | - | $5.69M(-22.4%) |
| Dec 2015 | $7.33M(-46.0%) | $7.33M(-14.0%) |
| Sep 2015 | - | $8.52M(-15.2%) |
| Jun 2015 | - | $10.05M(-14.1%) |
| Mar 2015 | - | $11.70M(-13.9%) |
| Dec 2014 | $13.59M(-8.2%) | $13.59M(-32.6%) |
| Sep 2014 | - | $20.14M(+39.6%) |
| Jun 2014 | - | $14.43M(-26.6%) |
| Mar 2014 | - | $19.65M(+32.7%) |
| Dec 2013 | $14.81M(+13.2%) | $14.81M(+20.3%) |
| Sep 2013 | - | $12.31M(+11.3%) |
| Jun 2013 | - | $11.06M(-0.5%) |
| Mar 2013 | - | $11.12M(-15.0%) |
| Dec 2012 | $13.08M(+11.7%) | $13.08M(+26.2%) |
| Sep 2012 | - | $10.36M(-13.9%) |
| Jun 2012 | - | $12.04M(-14.1%) |
| Mar 2012 | - | $14.02M(+19.7%) |
| Dec 2011 | $11.71M(-4.6%) | $11.71M(-4.5%) |
| Sep 2011 | - | $12.26M(-22.8%) |
| Jun 2011 | - | $15.89M(+61.4%) |
| Mar 2011 | - | $9.84M(-19.8%) |
| Dec 2010 | $12.27M(-13.0%) | $12.27M(-13.0%) |
| Sep 2010 | - | $14.12M(-28.7%) |
| Jun 2010 | - | $19.81M(+9.3%) |
| Mar 2010 | - | $18.12M(+28.4%) |
| Dec 2009 | $14.12M | $14.12M(-15.0%) |
| Sep 2009 | - | $16.61M(-0.4%) |
| Jun 2009 | - | $16.69M(+48.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $11.26M(-31.3%) |
| Dec 2008 | $16.40M(-26.8%) | $16.40M(+2.9%) |
| Sep 2008 | - | $15.94M(+0.1%) |
| Jun 2008 | - | $15.93M(-17.7%) |
| Mar 2008 | - | $19.34M(-13.6%) |
| Dec 2007 | $22.40M(-26.6%) | $22.40M(-21.9%) |
| Sep 2007 | - | $28.68M(+1.5%) |
| Jun 2007 | - | $28.25M(-1.8%) |
| Mar 2007 | - | $28.78M(-5.6%) |
| Dec 2006 | $30.50M(+75.4%) | $30.50M(+16.6%) |
| Sep 2006 | - | $26.15M(+12.0%) |
| Jun 2006 | - | $23.36M(+6.8%) |
| Mar 2006 | - | $21.87M(+25.8%) |
| Dec 2005 | $17.39M(-23.2%) | $17.39M(+14.1%) |
| Sep 2005 | - | $15.24M(-6.2%) |
| Jun 2005 | - | $16.25M(+12.3%) |
| Mar 2005 | - | $14.47M(-36.0%) |
| Dec 2004 | $22.63M(+71.0%) | $22.63M(+9.2%) |
| Sep 2004 | - | $20.72M(+33.6%) |
| Jun 2004 | - | $15.51M(+4.4%) |
| Mar 2004 | - | $14.85M(+12.2%) |
| Dec 2003 | $13.23M(-8.1%) | $13.23M(-2.6%) |
| Sep 2003 | - | $13.58M(-2.4%) |
| Jun 2003 | - | $13.91M(-44.5%) |
| Mar 2003 | - | $25.05M(+73.9%) |
| Dec 2002 | $14.40M(+640.2%) | $14.40M(-2.9%) |
| Sep 2002 | - | $14.84M(+90.4%) |
| Jun 2002 | - | $7.79M(+44.0%) |
| Mar 2002 | - | $5.41M(+178.1%) |
| Dec 2001 | $1.95M(-7.2%) | $1.95M(+8.6%) |
| Sep 2001 | - | $1.79M(-4.0%) |
| Jun 2001 | - | $1.87M(-15.1%) |
| Mar 2001 | - | $2.20M(+4.8%) |
| Dec 2000 | $2.10M(-41.8%) | $2.10M(-12.2%) |
| Sep 2000 | - | $2.39M(-0.0%) |
| Jun 2000 | - | $2.39M(+26.2%) |
| Mar 2000 | - | $1.89M(-47.4%) |
| Dec 1999 | $3.60M(+80.0%) | $3.60M(+38.4%) |
| Sep 1999 | - | $2.60M(+30.0%) |
| Jun 1999 | - | $2.00M(-13.0%) |
| Mar 1999 | - | $2.30M(+15.0%) |
| Dec 1998 | $2.00M(-20.0%) | $2.00M(-4.8%) |
| Sep 1998 | - | $2.10M(0.0%) |
| Jun 1998 | - | $2.10M(+23.5%) |
| Mar 1998 | - | $1.70M(-32.0%) |
| Dec 1997 | $2.50M(+127.3%) | $2.50M(+31.6%) |
| Sep 1997 | - | $1.90M(+5.6%) |
| Jun 1997 | - | $1.80M(+28.6%) |
| Mar 1997 | - | $1.40M(+75.0%) |
| Dec 1996 | $1.10M(-38.9%) | - |
| Sep 1996 | - | $800.00K(-55.6%) |
| Jun 1996 | $1.80M(0.0%) | $1.80M(+20.0%) |
| Mar 1996 | - | $1.50M(0.0%) |
| Dec 1995 | - | $1.50M(-11.8%) |
| Sep 1995 | - | $1.70M(-5.6%) |
| Jun 1995 | $1.80M(+5.9%) | $1.80M(+20.0%) |
| Mar 1995 | - | $1.50M(+7.1%) |
| Dec 1994 | - | $1.40M(-6.7%) |
| Sep 1994 | - | $1.50M(-11.8%) |
| Jun 1994 | $1.70M | $1.70M(+13.3%) |
| Mar 1994 | - | $1.50M(-6.3%) |
| Dec 1993 | - | $1.60M(0.0%) |
| Sep 1993 | - | $1.60M |
FAQ
- What is Moderna annual total liabilities?
- What is the all time high annual total liabilities for Moderna?
- What is Moderna annual total liabilities year-on-year change?
- What is Moderna quarterly total liabilities?
- What is the all time high quarterly total liabilities for Moderna?
- What is Moderna quarterly total liabilities year-on-year change?
What is Moderna annual total liabilities?
The current annual total liabilities of MRNA is $3.24B
What is the all time high annual total liabilities for Moderna?
Moderna all-time high annual total liabilities is $10.52B
What is Moderna annual total liabilities year-on-year change?
Over the past year, MRNA annual total liabilities has changed by -$1.33B (-29.11%)
What is Moderna quarterly total liabilities?
The current quarterly total liabilities of MRNA is $2.64B
What is the all time high quarterly total liabilities for Moderna?
Moderna all-time high quarterly total liabilities is $10.80B
What is Moderna quarterly total liabilities year-on-year change?
Over the past year, MRNA quarterly total liabilities has changed by -$1.27B (-32.57%)